CancerIQ Raises $14M Series B Funding
Summary
CHICAGO, IL, CancerIQ, announced it closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund and Amgen Ventures. CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, announced it closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), as well as CancerIQs Series A lead investor, HealthX Ventures, also participated in the Series B round. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected